Decarboxylation that Delivers
Click the link to read the full The GrowthOp article or read the excerpt below.
“The idea of having a bag of weed and then going to smoke it… patients and physicians, at large, are never going to accept that practice as true medicine,” says Har Grover, CEO and chairman of Scientus Pharma, when explaining the company’s focus on non-smokable products during a facility tour in late November.
A strategy, perhaps, not too far from the truth, since consumption of medical cannabis oils in Canada has been on a steady rise: the amount of cannabis oils in LPs’ inventories rose from 20,802 kg in April 2018 to 47,803 kg in September 2018, as reported by Government of Canada.
With cannabis oils, however, there is a challenge. When it comes to smoking or vaping, cannabinoids are automatically activated when heated—during a process called decarboxylization—turning CBDA into CBD, or THCA into THC, a conversion crucial for desired results both medically or recreationally.
But when it comes to cannabis oils, since there’s often no heat involved during consumption, it’s important that oil be adequately decarboxylated as part of the manufacturing process.